2-Hydroxyglutarate in onco-pathway: a metabolic driver of proto-oncogene activation
-
By
-
Masthan Thamim
-
Debdas Dhabal
-
M. M. Balamurali
-
Krishnan Thirumoorthy
-
April 30, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
Memorial Sloan Kettering Cancer Center
New York, NY
Key Differentiators
- Cancer Metabolism
- Molecular Oncology
- Translational Research
-
#2
Dana-Farber Cancer Institute
Boston, MA
Key Differentiators
- Cancer Biology
- Metabolic Therapeutics
- Epigenetics
-
#3
MD Anderson Cancer Center
Houston, TX
Key Differentiators
- Cancer Metabolism
- Molecular Oncology
- Clinical Trials
-
#4
Broad Institute of MIT and Harvard
Cambridge, MA
Key Differentiators
- Cancer Genomics
- Metabolomics
- Epigenetics
-
#5
University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Key Differentiators
- Cancer Metabolism
- Molecular Oncology
- Translational Medicine
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.